CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NAM project addresses the urgent issue of antibacterial resistance by discovering new antibacterial compounds from endophytes, developing innovative approaches using antimicrobial peptides, and studying the mechanisms of action of these compounds. This multidisciplinary collaboration between academia and industry a…
Antibacterial resistance is spreading globally at an alarming rate and continues to increase.
New potent antibacterial agents and therapies are therefore continually needed.
In recent years, new antibacterial compounds have mainly been additions to the existing classes of drugs and very few new structures have been developed.
Pharmaceutical industry has little interest in developing novel structures due to high investment and low profit expectancy.
The derivatives of existing drugs typically rai…
OULUN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Bagsvaerd
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Finland, OULU
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, Trieste
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Bonn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
